Latest podcast episode – Tailoring drug therapy to your genes

Research / 03 August 2021

Photo: iStock

Drug Safety Matters dives into the fascinating field of pharmacogenomics and the implications it has for tailored treatments and safer prescribing practices.


Genetic variation is one of the reasons people differ in their response to medicines. Understanding that variation can inform more refined choices of drugs and doses – ultimately preventing undesired side effects. Join us as we discuss past, present and future of pharmacogenomics with Uppsala Monitoring Centre’s Qun-Ying Yue.

 

Subscribe by visiting the Drug Safety Matters website or listen in right here:

 

Read more

Pharmacogenomics group aims to refine patient safety options

Africa integral to evolution of pharmacogenomics research

Related Articles

Towards a safer deprescribing practice – How can we routinely and safely stop unnecessary medicine use?

Micke testar

COVID-19 top priority for research team

You may also like

Towards a safer deprescribing practice – How can we routinely and safely stop unnecessary medicine use?

With multiple medicine use on the rise, a UK study has set out to gather evidence for safer practices to get patients off the drugs they no longer need.

Research / 16 June 2021

COVID-19 top priority for research team

Check in with UMC’s head of pharmacovigilance science to catch up with her team’s current research priorities.

Research / 09 April 2021

Micke testar

Research / 04 June 2021

Our website uses cookies

Cookies are small text files held on your computer. They allow us to give you the best browsing experience possible and mean that we can understand how you use our site. Some cookies have already been set. You can delete and block cookies but parts of our site won't work without them. By using our website you accept our use of cookies.

Find out more